Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Neurology

Bulbar vs. Limb-Onset ALS: What Is the Difference?

At a Glance

The primary difference between bulbar-onset and limb-onset ALS is where symptoms first appear. Limb-onset begins with weakness in the arms or legs. Bulbar-onset starts in the brainstem, causing early speech and swallowing difficulties. Both types eventually overlap as the disease progresses.

ALS is categorized by where in the body symptoms first appear. The primary difference between bulbar-onset ALS and limb-onset ALS is which muscles are affected first, which in turn influences how the disease progresses and when certain medical interventions are needed [1][2]. Limb-onset begins with weakness in the arms or legs, while bulbar-onset begins with weakness in the muscles of the face, mouth, and throat, affecting speech and swallowing first.

Receiving a diagnosis of Amyotrophic Lateral Sclerosis (ALS) is overwhelming, and learning about the different ways the disease can present can feel daunting. However, understanding your specific type of ALS is a crucial first step in building the right care team and planning your symptom management.

Limb-Onset ALS

Limb-onset ALS is the most common form of the disease. In this type, the motor neurons (the nerve cells that control muscle movement) first begin to degenerate in the spinal cord, leading to initial symptoms in the arms or legs [1]. Symptoms often begin asymmetrically, meaning you might notice weakness in just one hand or one foot before it affects the other side.

If you have limb-onset ALS, early signs often include:

  • In the legs: Frequent tripping, stumbling, or a “foot drop” (difficulty lifting the front part of the foot).
  • In the arms: Dropping items, difficulty buttoning a shirt, or a noticeably weaker grip.
  • Muscle twitching, cramping, or visible muscle thinning (atrophy) in the affected limbs.

Because the disease starts in the extremities, functions like talking, chewing, swallowing, and breathing usually remain normal in the early stages of limb-onset ALS.

Bulbar-Onset ALS

Bulbar-onset ALS accounts for about 25% to 30% of cases. It begins when motor neurons in the brainstem—the area of the brain known as the “bulb”—are affected first. These nerves control the muscles of the face, mouth, and throat [2].

Early signs of bulbar-onset ALS typically include:

  • Dysarthria: Slurred, slow, or “thick” speech, and sometimes a nasal-sounding voice [2].
  • Dysphagia: Difficulty chewing or swallowing, which can lead to coughing or choking during meals [3].
  • Unexplained weight loss due to the effort and difficulty required to eat.
  • Pseudobulbar Affect (PBA): Many bulbar patients experience PBA, a neurological condition characterized by sudden, uncontrollable episodes of laughing or crying that do not necessarily match how the person is actually feeling [4]. It is important to know that this is a physical symptom of the disease, not a sign of depression or dementia [5].
  • Behavioral and Cognitive Changes: Separately from PBA, bulbar-onset is also more frequently linked to certain cognitive or behavioral shifts [6].

Differences in Progression and Outlook

ALS is a progressive condition, meaning that over time, the symptoms of limb-onset and bulbar-onset disease eventually overlap. A person who starts with limb weakness will generally develop speech and swallowing difficulties later on, and vice versa.

However, their early timelines often look different. Bulbar-onset ALS is generally associated with a faster rate of progression [7]. Statistically, it is linked to a shorter average survival time compared to limb-onset ALS [8]. It is deeply important to remember that these are just statistical averages—every person’s journey with ALS is unique, and disease progression varies widely from individual to individual.

Because bulbar-onset affects the throat and swallowing muscles early on, the risk of rapid nutritional decline and aspiration pneumonia (a lung infection caused by inhaling food or liquid) is much higher in the early stages [9].

How Early Interventions Differ

The type of onset heavily influences your immediate care plan. A proactive approach allows you to preserve your quality of life for as long as possible.

  • Speech and Communication: Because bulbar-onset affects speech early, early referral to a speech-language pathologist is vital. Patients can engage in voice banking (recording your natural voice to create a personalized synthetic voice for a communication device) or message banking (recording specific, meaningful phrases in your own voice) [10]. This should be done as soon as possible after diagnosis, while the voice is still strong [11].
  • Feeding Tubes (Gastrostomy): Patients with bulbar-onset ALS often need a feeding tube much earlier in their disease course to maintain their weight and safely receive hydration and medication [9][12]. Timing is critical: placing a feeding tube becomes more hazardous if delayed until respiratory function has significantly declined [13][14]. Importantly, getting a feeding tube does not always mean you must immediately stop eating by mouth; many patients continue to eat safe foods for pleasure while using the tube for their primary nutrition. For limb-onset patients, this intervention is usually not needed until much later.
  • Breathing Support: Non-invasive ventilation (NIV)—such as a mask worn over the nose and/or mouth to help with breathing—is a standard treatment for ALS. However, bulbar symptoms can complicate the use of NIV. Weak facial and throat muscles may make it harder to maintain a tight mask seal, and poor swallowing can increase the risk of air being pushed into the stomach [7].

Regardless of the onset type, regular monitoring by a multidisciplinary ALS clinic is essential [15]. These clinics bring together a team of specialists—including neurologists, physical and occupational therapists, respiratory therapists, speech-language pathologists, and dietitians—in one place, ensuring that interventions are introduced safely and thoughtfully, in accordance with your personal goals [15][16].

Common questions in this guide

What are the early signs of limb-onset ALS?
Early signs often include frequent tripping, foot drop, difficulty buttoning shirts, and muscle twitching or cramping in the arms or legs. These symptoms usually begin asymmetrically, meaning you might notice weakness in just one hand or foot before it affects the other side.
What does bulbar-onset ALS mean?
Bulbar-onset ALS is a form of the disease that begins in the brainstem, first affecting the muscles of the face, mouth, and throat. Early symptoms typically include slurred speech, difficulty chewing and swallowing, and sometimes sudden, uncontrollable emotional outbursts.
Does bulbar-onset ALS progress faster than limb-onset?
Statistically, bulbar-onset ALS is associated with a faster rate of disease progression and a shorter average survival time compared to limb-onset ALS. However, every patient's journey is unique, and progression timelines can vary widely from person to person.
When should someone with bulbar-onset ALS get a feeding tube?
Patients with bulbar-onset ALS often need a feeding tube earlier in their disease course to maintain weight, stay safely hydrated, and avoid aspiration pneumonia. Discussing this option early is critical, as the placement procedure becomes more hazardous if delayed until breathing function declines.
Why is voice banking important for bulbar-onset patients?
Voice banking allows you to record your natural voice to create a personalized synthetic voice for a communication device. It is highly recommended that bulbar-onset patients begin this process immediately after diagnosis, while their voice is still strong and clear.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my specific onset type, when should we start monitoring my breathing and swallowing function?
  2. 2.Should I be referred to a speech-language pathologist right away to begin voice banking?
  3. 3.How will my onset type affect my options for non-invasive ventilation (NIV) if my breathing becomes weaker?
  4. 4.Given my symptoms, when is the safest time to discuss the placement of a feeding tube?
  5. 5.Can you refer me to a multidisciplinary ALS clinic so I can meet with specialized therapists and dietitians?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    The burden of upper motor neuron involvement is correlated with the bilateral limb involvement interval in patients with amyotrophic lateral sclerosis: a retrospective observational study.

    Wu J, Ye S, Liu X, et al.

    Neural regeneration research 2025; (20(5)):1505-1512 doi:10.4103/NRR.NRR-D-23-01359.

    PMID: 39075916
  2. 2

    Exploring the Impact of Amyotrophic Lateral Sclerosis on Otolaryngological Functions.

    Candelo E, Vasudevan SS, Orellana D, et al.

    Journal of voice : official journal of the Voice Foundation 2024; doi:10.1016/j.jvoice.2024.07.025.

    PMID: 39138039
  3. 3

    Tongue shear wave elastography for bulbar dysfunction in amyotrophic lateral sclerosis.

    Yanagawa K, Ike M, Aoyama A, et al.

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2025; (179()):2111367 doi:10.1016/j.clinph.2025.2111367.

    PMID: 41004918
  4. 4

    Altered resting-state functional activity in isolated pontine infarction patients with pathological laughing and crying.

    Liu T, Li J, Huang S, et al.

    Oncotarget 2017; (8(48)):84529-84539 doi:10.18632/oncotarget.19307.

    PMID: 29137445
  5. 5

    Pseudobulbar affect: clinical associations, social impact and quality of life implications - Lessons from PLS.

    Finegan E, Kleinerova J, Hardiman O, et al.

    Journal of neurology 2025; (272(4)):266 doi:10.1007/s00415-025-12971-y.

    PMID: 40072589
  6. 6

    Factors associated with Edinburgh Cognitive and Behavioural ALS Screen (ECAS) alteration at time of diagnosis, in amyotrophic lateral sclerosis.

    Ginanneschi F, Pucci B, Casali S, et al.

    Clinical neurology and neurosurgery 2024; (245()):108499 doi:10.1016/j.clineuro.2024.108499.

    PMID: 39146722
  7. 7

    A novel mutation of the C-terminal amino acid of FUS (Y526C) strengthens FUS gene as the most frequent genetic factor in aggressive juvenile ALS.

    Corcia P, Danel V, Lacour A, et al.

    Amyotrophic lateral sclerosis & frontotemporal degeneration 2017; (18(3-4)):298-301 doi:10.1080/21678421.2016.1265564.

    PMID: 28054830
  8. 8

    Prognostic Factors in Amyotrophic Lateral Sclerosis: A Population-Based Study.

    Moura MC, Novaes MR, Eduardo EJ, et al.

    PloS one 2015; (10(10)):e0141500 doi:10.1371/journal.pone.0141500.

    PMID: 26517122
  9. 9

    Early assessment in bulbar-onset amyotrophic lateral sclerosis detects similar rates of nocturnal desaturation and orthopnoea compared to non-bulbar-onset disease.

    Luu S, McGuiness OA, Menadue C, et al.

    Sleep & breathing = Schlaf & Atmung 2025; (30(1)):3 doi:10.1007/s11325-025-03527-5.

    PMID: 41348294
  10. 10

    Exploring Voice Banking as an Alternative Augmentative Communication Strategy for Individuals with Dysphonia, Aphonia, and Dysarthria: A Scoping Review.

    Pu S, Sawyer A, Levinson C, et al.

    Journal of voice : official journal of the Voice Foundation 2025; doi:10.1016/j.jvoice.2025.10.018.

    PMID: 41219095
  11. 11

    Stage-Based Communication Rehabilitation in Amyotrophic Lateral Sclerosis (ALS): A Review of Strategies for Enhancing Quality of Life.

    Jackson MC, Azarraga RB, Fraix MP, Agrawal DK

    Archives of internal medicine research 2025; (8(4)):359-371 doi:10.26502/aimr.0230.

    PMID: 41626035
  12. 12

    Factors That Predict Endoscopic Evaluation and Gastrostomy Placement in Patients With Neurologic Disorders and Dysphagia.

    Chase RC, Cortes P, Lamb CJ, et al.

    Cureus 2025; (17(7)):e88853 doi:10.7759/cureus.88853.

    PMID: 40881531
  13. 13

    Gastrostomy placement in patients with amyotrophic lateral sclerosis: assessment of risk factors for post-procedural respiratory failure.

    An TJ, Jang S, Hering K, et al.

    Amyotrophic lateral sclerosis & frontotemporal degeneration 2024; (25(7-8)):680-686 doi:10.1080/21678421.2024.2384994.

    PMID: 39086006
  14. 14

    The yin and yang of gastrostomy in the management of ALS: Friend or foe?

    de Carvalho M, Gooch CL

    Neurology 2017; (89(14)):1435-1436 doi:10.1212/WNL.0000000000004547.

    PMID: 28864678
  15. 15

    Control in the absence of choice: A qualitative study on decision-making about gastrostomy in people with amyotrophic lateral sclerosis, caregivers, and healthcare professionals.

    van Eenennaam RM, Rave N, Kruithof WJ, et al.

    PloS one 2023; (18(9)):e0290508 doi:10.1371/journal.pone.0290508.

    PMID: 37682899
  16. 16

    Patient-centered decision making in amyotrophic lateral sclerosis: where are we?

    Hogden A, Crook A

    Neurodegenerative disease management 2017; (7(6)):377-386 doi:10.2217/nmt-2017-0026.

    PMID: 29165027

This page provides educational information about the different onset types of ALS. It is not intended as medical advice. Always consult your neurologist or multidisciplinary ALS care team regarding your specific symptoms, prognosis, and care plan.

Get notified when new evidence is published on Amyotrophic lateral sclerosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.